
Etranger Pharma Private Limited
About Etranger Pharma Private Limited
Data last updated:
Etranger Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 11 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24302PN2017PTC173795. Its GSTIN is 27AAECE8739K1Z3 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Asif Ali Khradi and Mohammed Sameer Ahamadsab Kharadi.
Its last annual general meeting (AGM) was held on 23 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sara Residency S. No. 43 H. No. 1B Nr. Unity Park Kondhwa Khurd, Pune, Maharashtra, India – 411048.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.09 Lakh, a growth of 120% compared to the previous year. For the same year it recorded a net loss of ₹5,570 (net margin -5.1%) and EBITDA of -₹5,100 (EBITDA margin -4.7%). Revenue has grown at a compounded annual rate (CAGR) of 30% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Etranger Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressSara Residency S. No. 43 H. No. 1B Nr. Unity Park Kondhwa Khurd, Pune, Maharashtra, India – 411048
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Etranger Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Etranger Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Etranger Pharma Private Limited, buy the company report.
Financials of Etranger Pharma Private Limited
FY 2025 filings availableEtranger Pharma Private Limited reported revenue of ₹1.09 Lakh (up 120% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 120% growth in the latest year. EBITDA fell 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5,100 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5,570 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.7% | ||||
| Net Profit Margin | -5.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Etranger Pharma Private Limited, buy the company report.
Board of directors of Etranger Pharma Private Limited
Etranger Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asif Ali Khradi | Director | 11 Dec 2017 | 8 Years 11 Months | Current |
| Mohammed Sameer Ahamadsab Kharadi | Director | 16 Feb 2019 | 7 Years 9 Months | Current |
Peer comparison
Etranger Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MMP Pharmaceuticals Private Limited | ₹1.16 Lakh (FY 2025) | 258.0% | Thane, Maharashtra, India | |||
| Gaghan's Life Sciences Private Limited | ₹1.15 Lakh (FY 2025) | Hyderabad, Telangana, India | ||||
| Deera Meditech Private Limited | ₹1.13 Lakh (FY 2025) | Guntur, Andhra Pradesh, India | ||||
| Aegis Forging Limited | ₹1.12 Lakh (FY 2025) | 10.0% | Pune, Maharashtra, India | |||
| Va Medi Pharma Private Limited | ₹1.11 Lakh (FY 2023) | Ambala, Haryana, India | ||||
| Etranger Pharma Private Limitedthis company | ₹1.09 Lakh (FY 2025) | -₹5,570 | -5.1% | 120.0% | Pune, Maharashtra, India | |
| CV Industries Private Limited | ₹1.03 Lakh (FY 2024) | 26.0% | Nashik, Maharashtra, India | |||
| Onor Cosmetics and Perfumery Private Limited | ₹1.01 Lakh (FY 2025) | Bangalore, Karnataka, India | ||||
| Dr. Sethis Laboratories Private Limited | ₹1 Lakh (FY 2025) | Assam, India | ||||
| Ropana Healthcare Private Limited | ₹99,999 (FY 2024) | Ernakulam, Kerala, India | ||||
| Applied Science Innovations Private Limited. | ₹96,500 (FY 2025) | 165.0% | Pune, Maharashtra, India |
To see the full peer comparison of Etranger Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Etranger Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Etranger Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Etranger Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECE8739K1Z3 | Maharashtra | Active | 06 Feb 2018 |
To see the full GST registrations and return filing status of Etranger Pharma Private Limited, buy the company report.
Recent activity
Etranger Pharma Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Mohammed Sameer Ahamadsab Kharadi was appointed as Director on 16 Feb 2019.
Frequently asked questions
Etranger Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 11 December 2017 (9+ years old) and is registered under CIN U24302PN2017PTC173795.
Etranger Pharma has 2 current directors:
- Asif Ali Khradi - Director
- Mohammed Sameer Ahamadsab Kharadi - Director
The latest financial statements of Etranger Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 July 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Etranger Pharma is 27AAECE8739K1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Etranger Pharma is U24302PN2017PTC173795. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Etranger Pharma was incorporated on 11 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Etranger Pharma by revenue are MMP Pharmaceuticals Private Limited, Gaghan's Life Sciences Private Limited, Deera Meditech Private Limited, Aegis Forging Limited, Va Medi Pharma Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Mohammed Sameer Ahamadsab Kharadi was appointed as Director on 16 Feb 2019. Zuber Nabirasool Bagban ceased to be Director on 16 Feb 2019. Asif Ali Khradi was appointed as Director on 11 Dec 2017. Etranger Pharma has 4 board changes on record in total.
The registered office of Etranger Pharma is at Sara Residency S. No. 43 H. No. 1B Nr. Unity Park Kondhwa Khurd, Pune, Maharashtra, India – 411048.
Etranger Pharma operates in the food and beverages industry, in the manufacturing segment.
The compliance status of Etranger Pharma is compliant as of 29 July 2026. The company is actively filing with the Registrar of Companies.

